China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case

By  Keith Bradsher and Chris Buckley, Published on The New York Times on September 19th, 2014 HONG KONG — China, a country that has enticed the world’s multinationals to invest billions of dollars over the past decade with the prospectof selling to 1.4 billion people, sent its strongest signal yet on Friday of a tougher climate for those companies… [ Read More ]    

Related  Event

  ACI’s upcoming 3rd Asia-Pacific Summit on Anti-Corruption Compliance and Risk Management  keynote address will feature a Senior Regulator from the Shanghai Administration for Industry and Commerce discussing current anti-corruption landscape in China.  View the complete agenda. 

Tags: Anti-corruption, Bribes, FCPA, Singapore